RxDoctor Payments Data

Jenna Wald, MD

MOHS-Micrographic Surgery · Mesa, AZNPI 1003159872

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 34.2% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in AZ, where the typical reported total is $1,522.

$1,456in general payments, 2019–2025

Across 56 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • Sanofi$196
  • Amgen$191
  • Lilly USA, LLC$132
  • Regeneron Healthcare Solutions, Inc.$95
  • UCB, Inc.$62
  • plus $282 from 11 others

What the payments were for

  • Food & beverage$1,456100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,456 in reported general payments places this provider in the 45th percentile of 38 mohs-micrographic surgery providers in Arizona.

See all mohs-micrographic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$846,491
Medicare patients
751
Services billed
2,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin46$336
Doxycycline Monohydrate15$95
Cephalexin34$91

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →